Search PubMed⌕ Search

Biomedical subjects

M A Simon

Publications and source records attributed to M A Simon.

186 records · Page 11Linked to original sources

Intravenous regional anesthesia with 0.5% articaine, 0.5% lidocaine, or 0.5% prilocaine. A double-blind randomized clinical study.

BACKGROUND AND OBJECTIVES: The purpose of this study was to compare the effectiveness of three local anesthetic agents for intravenous regional anesthesia in the upper limb. Side effects and plasma concentrations of the drugs in the doses administered for IVRA were also studied. METHODS: Thirty patients in ASA groups I and II received intravenous regional anesthesia for surgery of the upper limb. In a double-blind prospective study, they were randomly allocated to receive one of three local anesthetics: articaine, lidocaine, or prilocaine. Patients received 40 mL of a 0.5% solution of the local anesthetic. The onset time of sensory block was assessed by pinprick and the extent of motor block was was scored as 0-3. Plasma concentrations of local anesthetics were determined in all patients from serial arterial blood samples drawn at predetermined times before and after tourniquet release. RESULTS: The onset time of sensory block was significantly shorter (2.5 minutes) in the articaine group than in the lidocaine group (11.1 minutes) or the prilocaine group (10.9 minutes) (Scheffe, P < .05). Development of motor block was equal in all three groups (score 2). Estimation of plasma concentrations by high performance liquid chromatography showed that the peak level in all 30 patients was reached immediately after release of the tourniquet; plasma concentrations thereafter gradually declined. Maximum concentrations of articaine, lidocaine, and prilocaine were, 1.85, 8.5, and 4.4 micrograms/mL, respectively. No signs of local anesthetic toxicity of the cardiovascular or central nervous systems were seen. CONCLUSION: Articaine had the fastest onset of sensory block and the lowest peak plasma concentration of the three local anesthetics when used for intravenous regional anesthesia.

Adult↗

The epidemiology of organophosphate poisoning in urban Zimbabwe from 1995 to 2000.

The objective of this study was to examine current organophosphate usage in Zimbabwe. A cross-sectional descriptive study was done to determine the trends in admissions for organophosphate poisonings in an urban Zimbabwe hospital from 1995 to 2000. Variables such as sex, age, season, geographic area, and intent were examined. In 183,569 records, 599 cases of organophosphate poisoning were found. Organophosphate poisonings increased by 320% over the six years. The male and female admissions' rates were similar (48% vs 52%); 82% of the patients were less than 31 years old. Suicide was the predominant reason for poisoning (74%). Of admissions of children under the age of 10, 62% were due to accidental ingestion. Mortality from organophosphate poisonings was 8.3% over the six years. Organophosphate poisoning is increasing rapidly. In the background of this alarming trend is the physical, mental, and social state of a Zimbabwean society wrought with hardships.

Admitting Department, Hospital↗

Plasma concentrations after high doses of mepivacaine with epinephrine in the combined psoas compartment/sciatic nerve block.

A combination of psoas compartment block and sciatic nerve block was performed with a total dose of 731.5 mg mepivacaine (55 ml, 1.33%) with epinephrine (1:600,000) in patients scheduled for orthopedic surgery on one leg. In 20 patients, arterial blood samples were collected at timed intervals over a 6-hour period to determine the mepivacaine plasma concentration. In all patients, good sensory and motor blocks were obtained and no analgesics were required during surgery. Despite the high dose of mepivacaine, the plasma concentrations stayed below 6.0 micrograms/ml, with one exception, although no clinical signs of local anesthetic toxicity were observed. Plasma pharmacokinetic variables of mepivacaine were as follows: Cmax: 4.22 mg.l-1 (SD, 1.28); Tmax: 0.99 hours (SD, 0.76); T1/2: 3.25 hours (SD, 1.12); CL 0.55 1.hour-1.kg-1.

Adult↗

Clinical and pathologic findings in infant rhesus macaques infected with SIVsmm by maternal transmission.

Three of 12 infant rhesus macaques became infected at 9 to 12 months of age with SIVsmm through maternal-infant transmission. Clinical problems seen in one or more infants included decreased CD4 cells, hypergammaglobulinemia, diarrhea, weight loss, anemia, bacterial infections, and terminal respiratory and CNS problems. Gross and histologic lesions due to both primary SIV infection and opportunistic infections were observed. The SIV-infected infants had clinical, immunologic, and pathologic similarities to those seen in pediatric HIV infection.

Animals↗